Under the deal, biOasis will conduct certain experiments using its technology, as it relates to the delivery of therapeutic compounds owned by UCB for CNS disorders. biOasis Technologie
As part of the expansion, the companies have renewed collaboration in Brazil and Argentina and also extended the partnership to Australia where Galderma will have exclusive promotion and
The double-blind, multicenter trial led by AVEO is designed to assess the efficacy profile of tivozanib combination therapy with paclitaxel against placebo combination therapy with paclitaxel in advanced
The contract research organization will leverage the platform that is compliant with 21 CFR Part 11 to simplify study management and reduce redundancies accompanying paper-based studies. WCT chief
The new complex, which is part of $100m complex, is a specialized branch for research, development, production and marketing of anti-cancer drugs globally. The complex includes an oral
IO Healthcare is expected to enable the earlier application of clinical information to increase research and development by adding clinical, genomic, metabolic and proteomic information to the platform’s
ShlomoYanai in his new role, will work with the company’s other directors and its leadership team to formulate and execute Cambrex’s growth strategies. Cambrex board of directors chairman
Using the company’s lentiviral vector technology, the anti-HIV therapeutic vaccine induces the cellular immune system for the removal of infected cells. The double-blind, controlled, placebo study, which will
Under the $84.5m agreement, Mundipharma and its independent associated companies across the globe will acquire intellectual property rights, excluding China, of Northlake International’s lead product NL-101 as well
Comprising of brands and product portfolio, Pfizer’s nutrition business complements Nestle’s infant nutrition business. The expanded acquisition enables Nestle to offer children with nutritious food and provide them
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.